A Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1018-1 and BR1018-2 in Healthy Adult Subjects

Clinical trial NCT05460364 · COMPLETED

Trial details

NCT number: NCT05460364
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension Hyperlipidemia (E.G., Hypercholesterolemia)

Start date: 2022-08-04
Primary completion: 2022-10-17
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.